On the way of the new strategies aimed to improve the efficacy of PD-1/PD-L1 immune checkpoint blocking mAbs in small cell lung cancer

Lignende værker

• Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab
  af: Nardone, Valerio, et al.
  Udgivet: (2020)
• Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade
  af: Correale, Pierpaolo, et al.
  Udgivet: (2020)
• Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade
  af: Nardone, Valerio, et al.
  Udgivet: (2021)
• How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
  af: Nardone, Valerio, et al.
  Udgivet: (2018)
• HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis
  af: Pierpaolo Correale, et al.
  Udgivet: (2020-08-01)